Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research discovery identifies new strategy against diabetes

16.06.2004


UCSF scientists have identified a protein on T cells of the immune system that triggers type 1 diabetes in mice when it interacts with another protein in the pancreas. They have shown that blocking the interaction prevents development of diabetes without weakening normal immune defenses or causing measurable side effects. The success provides a promising strategy against human type 1 diabetes, since the T cell protein has a counterpart in the human immune system, the scientists say.



The research is being published online June 15 by the journal Immunity.

The T cell protein, known as NKG2D, is a receptor on the surface of CD8+ T lymphocytes. The second protein, called RAE-1, has been found on cells infected by bacteria or viruses where it binds to NKG2D, alerting CD8+ T cells and other immune system molecules to attack and eliminate the pathogen.


T cells normally attack and destroy invading pathogens, but in type 1 diabetes, they mistakenly destroy the body’s insulin-producing islet cells.

"We knew that RAE-1 and its immune receptor were involved in anti-pathogen reactions," said Lewis Lanier, PhD, UCSF professor of microbiology and immunology and one of the paper’s senior authors. "The surprising finding is that RAE-1 is present in the pancreas of mice with autoimmune diabetes and if we prevent RAE-1 from binding its receptor on immune cells it can have a profound effect on autoimmunity. And treatment causes no observable side effects."

The researchers showed that treating the mice with an antibody that blocks the interaction of RAE-1 with the NKG2D receptor is completely effective against development of type 1 diabetes, Lanier said.

"You don’t need a calculator to tell the treatment group from the placebo group. It’s 100 percent effective," he said.

In addition to this newly discovered pathway, UCSF scientists have developed other strategies to block autoimmune disease by selectively interfering with receptors present on the surface of T cells. Jeffrey Bluestone, PhD, director of the UCSF Diabetes Center and a senior author with Lanier on the new paper, developed genetically engineered antibodies against CD3, another key T cell receptor that is required to trigger an autoimmune attack. The strategy has helped arrest early stages of human type 1 diabetes and rejection of islet cell transplantations in clinical trials. The treatment produces only minor side effects.

"The aim of selectively blocking molecules of the immune system is to prevent autoimmune disease without destroying all immune defenses -- and with a minimum of side effects, " Bluestone said. "Blocking the NKG2D receptor is even more selective than the anti-CD3 approach. What’s exciting about this finding is that if antibodies against this pathway can be developed into a treatment for human autoimmune disease, it would represent a very specific therapy targeting only a very small population of immune cells most involved in the disease."

The scientists studied diabetes development in "non-obese diabetic" (NOD) mice, considered the gold standard for type 1 diabetes research because disease progression in the mice mirrors the process in humans. In these mice, CD8+ T cells invade the pancreas when the mice are three weeks old, and diabetes develops 10 to 20 weeks later.

The team found that T cells invading the pancreas of the diabetic NOD mice expressed NKG2D and that insulin-producing islet cells in the pancreas produced the RAE-1 protein, promoting T cells to attack the islet cells. Normal, healthy mice did not produce RAE-1 in the pancreas. Treatment with the antibody that blocks RAE-1 from its receptor prevented development of diabetes in the NOD mice, the researchers reported.

The UCSF scientists expect that development of a "humanized" antibody to human NKG2D may provide an effective type 1 diabetes treatment. Other research has recently shown that the NKG2D on T cells may be involved in rheumatoid arthritis, so blocking NKG2D signaling may prove a useful strategy against a number of autoimmune diseases, the scientists conclude.


Lead author on the study is Kouetsu Ogasawara, PhD, a post-doctoral scientist in Lanier’s lab. Co-authors are Jessica A. Hamerman, PhD, and Lauren R. Ehrlich, PhD, postdoctoral fellows in Lanier’s lab; Helene Bour-Jordan, PhD, in the UCSF Diabetes Center; and Pere Santamaria, MD, PhD, professor of microbiology and infectious diseases at the Julia McFarlane Diabetes Research Centre, University of Calgary.

Support for the research was provided the National Institutes of Health, the Juvenile Diabetes Research Foundation and others.

Wallace Ravven | EurekAlert!
Further information:
http://www.ucsf.edu/

More articles from Health and Medicine:

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

Link Discovered between Immune System, Brain Structure and Memory

26.04.2017 | Life Sciences

New survey hints at exotic origin for the Cold Spot

26.04.2017 | Physics and Astronomy

NASA examines newly formed Tropical Depression 3W in 3-D

26.04.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>